Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...

A study has found that analyzing both genomic (DNA) and transcriptomic (RNA) information from blood samples allows for more ...

A blood test that looks at both DNA and RNA information may help identify Alzheimer’s disease patients more accurately, ...

Digestive system cancers, including hepatobiliary and gastrointestinal malignancies, remain a major global oncological burden ...

Citrus crops are among the world's most familiar fruits, but their genomes have remained difficult to interpret because of ...

According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by ...

Researchers created a DIA-MS atlas of 13,609 proteins across 2,856 samples from fetal, healthy adult, paired non-tumor, and ...

Explore how AI phenotypic screening transforms image-based drug discovery through advanced phenotypic data analysis and ML-driven cell-based assays.

Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...

This article explores how new technologies in plasma proteomics enable the simultaneous analysis of thousands of proteins, ...